D. Franz Et Al. , "Efficacy and Safety of Everolimus Based on Prior and Concomitant Antiepileptic Drugs in Patients with Tuberous Sclerosis Complex (TSC)-Associated Treatment-Refractory Seizures: A Subanalysis of the Phase 3 EXIST-3 Study," 70th Annual Meeting of the American-Academy-of-Neurology (AAN) , vol.90, Los-Angeles, Chile, 2018
Franz, D. Et Al. 2018. Efficacy and Safety of Everolimus Based on Prior and Concomitant Antiepileptic Drugs in Patients with Tuberous Sclerosis Complex (TSC)-Associated Treatment-Refractory Seizures: A Subanalysis of the Phase 3 EXIST-3 Study. 70th Annual Meeting of the American-Academy-of-Neurology (AAN) , (Los-Angeles, Chile).
Franz, D., Lawson, J., Yapici, Z., Ikeda, H., Polster, T., Nabbout, R., ... Curatolo, P.(2018). Efficacy and Safety of Everolimus Based on Prior and Concomitant Antiepileptic Drugs in Patients with Tuberous Sclerosis Complex (TSC)-Associated Treatment-Refractory Seizures: A Subanalysis of the Phase 3 EXIST-3 Study . 70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Chile
Franz, David Et Al. "Efficacy and Safety of Everolimus Based on Prior and Concomitant Antiepileptic Drugs in Patients with Tuberous Sclerosis Complex (TSC)-Associated Treatment-Refractory Seizures: A Subanalysis of the Phase 3 EXIST-3 Study," 70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Chile, 2018
Franz, David Et Al. "Efficacy and Safety of Everolimus Based on Prior and Concomitant Antiepileptic Drugs in Patients with Tuberous Sclerosis Complex (TSC)-Associated Treatment-Refractory Seizures: A Subanalysis of the Phase 3 EXIST-3 Study." 70th Annual Meeting of the American-Academy-of-Neurology (AAN) , Los-Angeles, Chile, 2018
Franz, D. Et Al. (2018) . "Efficacy and Safety of Everolimus Based on Prior and Concomitant Antiepileptic Drugs in Patients with Tuberous Sclerosis Complex (TSC)-Associated Treatment-Refractory Seizures: A Subanalysis of the Phase 3 EXIST-3 Study." 70th Annual Meeting of the American-Academy-of-Neurology (AAN) , Los-Angeles, Chile.
@conferencepaper{conferencepaper, author={David Franz Et Al. }, title={Efficacy and Safety of Everolimus Based on Prior and Concomitant Antiepileptic Drugs in Patients with Tuberous Sclerosis Complex (TSC)-Associated Treatment-Refractory Seizures: A Subanalysis of the Phase 3 EXIST-3 Study}, congress name={70th Annual Meeting of the American-Academy-of-Neurology (AAN)}, city={Los-Angeles}, country={Chile}, year={2018}}